Minimising diagnostic delay in lung cancer-Reference-Cited by-同舟云学术

Minimising diagnostic delay in lung cancer

Published:2019-02-23 Issue:4 Volume:74 Page:319-320
ISSN:0040-6376
Container-title:Thorax
language:en
Short-container-title:Thorax

Author:

Rogers Trevor Keith^ORCID

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference21 articles.

1. Office for National Statistics . Cancer survival in England: national estimates for patients followed up to 2017, 2019. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancersurvivalinengland/nationalestimatesforpatientsfollowedupto2017

2. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study

3. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up

4. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

5. Overdiagnosis in low-dose computed tomography screening for lung cancer;Patz;JAMA Intern Med,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry;Archivos de Bronconeumología;2024-07

2. Developing a risk prediction tool for lung cancer in Kent and Medway, England: cohort study using linked data;BJC Reports;2023-10-17

3. Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation;International Journal of Molecular Sciences;2023-08-25

4. Two missense variants of the epidermal growth factor receptor gene are associated with non small cell lung carcinoma in the subjects from Iraq;Molecular Biology Reports;2022-09-28

5. The rs1801280 SNP is associated with non-small cell lung carcinoma by exhibiting a highly deleterious effect on N-acetyltransferase 2;Journal of Cancer Research and Clinical Oncology;2022-09-01